| Name | TFC 007 |
|---|---|
| Synonyms |
N-{4-[4-(4-Morpholinylcarbonyl)-1-piperidinyl]phenyl}-2-phenoxy-5-pyrimidinecarboxamide
N-[4-[4-(4-Morpholinylcbonyl)-1-piperidinyl]phenyl]-2-phenoxy-5-pyrimidinecboxamide 5-Pyrimidinecboxamide, N-[4-[4-(4-morpholinylcbonyl)-1-piperidinyl]phenyl]-2-phenoxy N-(4-(4-(Morpholine-4-carbonyl)piperidin-1-yl)phenyl)-2-phenoxypyrimidine-5-cboxamide N-[4-[4-(4-Morpholinylcarbonyl)-1-piperidinyl]phenyl]-2-phenoxy-5-pyrimidinecarboxamide TFC 00 |
| Description | TFC-007, a selective hematopoietic prostaglandin D synthase (H-PGDS) inhibitor, show high inhibitory activity against H-PGDS enzyme (IC50 value of 83 nM). TFC-007 can be used for composing H-PGDS degradation inducer PROTAC(H-PGDS)-1 (TFC-007 binds to H-PGDS, and Pomalidomide binds to cereblon)[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Molecular Formula | C27H29N5O4 |
| Molecular Weight | 487.55 |
| Exact Mass | 487.221954 |
| LogP | 1.82 |
| Index of Refraction | 1.639 |